Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

We came across a bearish thesis on Hologic, Inc. on Value investing subreddit by Inevitable_Kick9706. In this article, we ...

Hologic HOLX is set to release third-quarter fiscal 2025 results on July 30, after the closing bell. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 0.9% decrease ...

The latest update on Hologic centers on a very slight trim to the fair value estimate, from about US$76.50 to about US$76.42 ...

If you are wondering whether Hologic's share price still offers value or if most of the opportunity is already priced in, you ...

I am initiating a Buy rating on Hologic, Inc. with a fair value of $81, as current risks are priced in. Hologic's strong diagnostic portfolio, recurring consumables revenue, and expanding assay menu ...

The valuation also compares favorably to peers QIAGEN QGEN and Abbott ABT, which have a P/S of 3.30X and 2.50X, respectively. Still, the stock trades at a premium to the broader Medical sector’s ...

Detailed price information for Cooper Companies (COO-Q) from The Globe and Mail including charting and trades.

We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at where Hologic, Inc. (NASDAQ:HOLX) stands against other firms that hit hard in ...

Private equity firms TPG and Blackstone (NYSE:BX) recently bid to acquire Hologic Inc. (NASDAQ:HOLX), valuing the U.S. medical technology company at over $16 billion. Hologic is an American medical ...